All Type of News
Lawmaker calls for crackdown on illegal pharmacies
Those pharmacists who run their pharmacy with less than ten square meters in area or in a two-story building should be punished to prevent the possible shady deals over prescription between doctors and pharmacists und...
54% of OTC users suffer heart burn
53.7 percent of those who take OTCs, such as digestives, have suffered from heart burn, according to a recently released survey.
The survey of 664 OTC users, conducted by a regional chapter of the Korean Pharmaceut...
Dispensing charge to rise 1.7%
The National Health Insurance Corporation said on October 18 that it will raise the dispensing fee of pharmacists by 1.7 percent beginning next year.
The Korean Dental Association and the Association of Korean Orie...
40% of consumers avoid clinics
Four in every 10 consumers prefer pharmacies to clinics in treatment of light disease, such as common cold, as they feel burdensome in visiting clinics due to the national health insurance's less coverage on patients ...
Intermittent dosing drives market growth
Although bisphosphonates are the mainstay of osteoporosis treatment, there is potential for new and innovative products to gain market share.
Products that offer intermittent dosing schedules are highly desirable i...
New drug policy corners local drug makers
The current positive list system, under which only medicines with proven efficacy and price-competitiveness will be covered by health insurance, is dealing a blow to the domestic pharmaceutical industry, a lawmaker sa...
Novo Nordisk is eyeing domestic diabetes market
Novo Nordisk Korea is intensifying heated marketing efforts on a new long-acting insulin analogue Levemir (insulin detemir) to strengthen its presence in local diabetes market.
Levemir is a long-acting basal insul...
KFDA approves Novartis's osteoporosis drug
Novartis Korea said on October 16 that the Korea Food and Drug Administration has approved its osteoporosis medicine Aclasta (zoledronic acid 5 mg) for treatment of women with postmenopausal osteoporosis.
A once-y...
Health watchdog to announce approval of new drugs and clinical tests every week
The Korea Food and Drug Administration plans to make public all information related to new drugs and clinical trials approved on a every week basis, said a KFDA official on October 17.
So far, the KFDA has regularl...
Pharmaceutical firms and pharmacists advised to promote OTCs
Domestic pharmaceutical makers and proprietors of pharmacy should focus on the development of over-the-counter drugs to survive in an era of the Korea-U.S. FTA, Moon Kyun-tae, Vice Chairman of the Korea Pharmaceutical...
